14 results on '"Shupp-Byrne D"'
Search Results
2. Prevention of bladder cancer in the FHIT knock-out mouse model with rofecoxib, a COX-2 inhibitor
- Author
-
Lenoir, J, D'Arca, Domenico, Gottardo, F, Bragantini, E, Wildemore, B, Shupp Byrne, D, Zanesi, N, Croce, Cm, Gomella, Lg, and Baffa, R.
- Subjects
bladder cancer ,knock-out mouse model ,FHIT tumor suppressor ,rofecoxib - Published
- 2006
3. The effects of hydrodistention on bladder surface mucin
- Author
-
Rofeim, O, primary, Shupp-Byrne, D, additional, Mulholland, G.S, additional, and Moldwin, R.M, additional
- Published
- 2001
- Full Text
- View/download PDF
4. 463 Can RT-PCR analysis of radical prostatectomy fluids contribute to clinical decision-making about the role of post-operative irradiation for prostate cancer?
- Author
-
Corn, B., primary, Moreno, J., additional, Gomella, L., additional, and Shupp-Byrne, D., additional
- Published
- 1995
- Full Text
- View/download PDF
5. Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells.
- Author
-
Fassan M, D'Arca D, Letko J, Vecchione A, Gardiman MP, McCue P, Wildemore B, Rugge M, Shupp-Byrne D, Gomella LG, Morrione A, Iozzo RV, and Baffa R
- Subjects
- Animals, Carrier Proteins, Cell Adhesion, Cell Line, Tumor, Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic, Humans, Male, Mice, Mice, Nude, Neoplasm Invasiveness, Neoplasm Staging, Phenotype, Tumor Stem Cell Assay, Tumor Suppressor Proteins metabolism, Down-Regulation genetics, Prostatic Neoplasms genetics, Prostatic Neoplasms pathology, Tumor Suppressor Proteins genetics
- Abstract
MITOSTATIN, a novel putative tumor suppressor gene induced by decorin overexpression, is expressed in most normal human tissues but is markedly down-regulated in advanced stages of mammary and bladder carcinomas. Mitostatin negatively affects cell growth, induces cell death and regulates the expression and activation levels of Hsp27. In this study, we demonstrated that ectopic expression of Mitostatin in PC3, DU145, and LNCaP prostate cancer cells not only induced a significant reduction in cell growth, but also inhibited migration and invasion. Moreover, Mitostatin inhibited colony formation in soft-agar of PC3 and LNCaP cells as well as tumorigenicity of LNCaP cells in nude mice. Conversely, targeting endogenous Mitostatin by siRNA and anti-sense strategies in PC3 and DU145 prostate cancer cells enhanced the malignant phenotype in both cell lines. In agreement of these anti-oncogenic roles, we discovered that Mitostatin was absent in ∼35% (n = 124) of prostate tumor samples and its overall reduction was associated with advanced cancer stages. Collectively, our findings indicate that MITOSTATIN may acts as a tumor suppressor gene in prostate cancer and provide a novel cellular and molecular mechanism to be further exploited and deciphered in our understanding of prostate cancer progression.
- Published
- 2011
- Full Text
- View/download PDF
6. Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor.
- Author
-
D'Arca D, LeNoir J, Wildemore B, Gottardo F, Bragantini E, Shupp-Byrne D, Zanesi N, Fassan M, Croce CM, Gomella LG, and Baffa R
- Subjects
- Acid Anhydride Hydrolases deficiency, Acid Anhydride Hydrolases genetics, Animals, Cyclooxygenase 2 Inhibitors therapeutic use, Female, Male, Mice, Mice, Knockout, Neoplasm Proteins deficiency, Neoplasm Proteins genetics, Precancerous Conditions prevention & control, Antineoplastic Agents therapeutic use, Lactones therapeutic use, Sulfones therapeutic use, Urinary Bladder Neoplasms prevention & control
- Abstract
Objectives: Aberrant or increased expression of cyclooxygenase-2 (COX-2) has been implicated in the pathogenesis of many diseases, including cancer. However, the exact mechanism by which COX-2 may influence tumorigenesis has yet to be described. To investigate the chemopreventive role of a COX-2 inhibitor, rofecoxib, in the development of urinary bladder cancer, we studied the effect of this drug in heterozygous and nullizygous fragile histidine triad (FHIT) gene-deficient mice in a chemically induced carcinogenesis model., Materials and Methods: Two-hundred eight mice consisting of 50 FHIT +/+, 63 FHIT +/- and 95 FHIT -/-, were divided into five treatment groups and followed up for 15 weeks. Mice were treated with freshly prepared solution of 0.1% or 0.01% N-butyl-N-(-4-hydroxybutyl)-nitrosamine (BBN) in their drinking water and rofecoxib was administered in mouse chow at 150 parts per million concentration. Mice were sacrificed, and accurate histological analysis of the bladder was performed., Results: Rofecoxib treatment significantly reduced the incidence of preneoplastic lesions/bladder tumors (P = 0.016). Comparing the incidence of neoplastic lesions in mice treated with rofecoxib and BBN (22/56, 39.3%) and mice treated only with BBN (32/57, 56.1%), a protective role of rofecoxib on the BBN tumor induction has been observed (P = 0.024). A similar result (P = 0.002) has been reached observing the incidence of mild and moderate dysplasia in mice treated with a lower concentration of BBN (8/16, 50.0% vs. 20/24, 83.3%).Moreover, as previously observed, a significant increase in neoplastic lesions in the FHIT +/- and FHIT -/- vs. FHIT +/+ mice after BBN treatment has been observed (P = 0.003)., Conclusions: These findings suggest that rofecoxib provides a therapeutic defense against bladder carcinogenesis in our model and confirmed that the FHIT knock-out mouse is a suitable system to study in vivo bladder carcinogenesis., (Copyright 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
7. Leukocyte subtypes in electroejaculates of spinal cord injured men.
- Author
-
Trabulsi EJ, Shupp-Byrne D, Sedor J, and Hirsch IH
- Subjects
- Adult, Case-Control Studies, Ejaculation, Electric Stimulation, Humans, Immunoenzyme Techniques, Infertility, Male etiology, Leukocyte Count, Male, Prospective Studies, Reactive Oxygen Species, Vibration, Leukocytes, Semen cytology, Spinal Cord Injuries complications
- Abstract
Objectives: To determine the level of leukocytospermia and seminal leukocyte subtypes in men with spinal cord injury (SCI) and to compare the findings with those of fertile, able-bodied controls., Design: Prospective, controlled clinical trial., Setting: University infertility practice., Participants: Thirteen able-bodied fertile men age matched to 17 men with SCI seeking reproductive rehabilitation., Interventions: Vibratory stimulation and antegrade electroejaculation for SCI group; manual ejaculation for controls., Main Outcome Measures: Immunoperoxidase technique on a panel of antileukocyte monoclonal antibodies to obtain the leukocyte subpopulations: B cells, T cells, neutrophils, and macrophages. Immunohistochemical staining and scoring to obtain the mean number of leukocytes and spermatozoa per high power field. The ratios of leukocyte to sperm and leukocyte subtype to sperm were tabulated., Results: Total white blood cells, neutrophils, and macrophages in the SCI population were significantly higher than those in the ejaculates of controls. Although not significantly elevated, all the other evaluated subsets were higher in the SCI group then in the controls., Conclusions: Leukocytospermia appears to be a pervasive abnormality in the semen recovered from men with SCI. The SCI group had significant elevations of total seminal leukocytes after electroejaculation. Compared with controls, men with SCI had significantly more seminal neutrophils and macrophages. Asthenospermia, universally observed in men with SCI, may be attributable, among other causes, to leukocytospermia., (Copyright 2002 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation)
- Published
- 2002
- Full Text
- View/download PDF
8. Interaction of bladder glycoprotein GP51 with uropathogenic bacteria.
- Author
-
Shupp Byrne DE, Sedor JF, Soroush M, McCue PA, and Mulholland SG
- Subjects
- Antibodies, Monoclonal, Enzyme-Linked Immunosorbent Assay, Humans, Immunohistochemistry, Mucins physiology, Glycoproteins urine, Urinary Tract Infections microbiology
- Abstract
Purpose: A major component of bladder surface mucin is a glycoprotein GP51 (molecular weight 51 kD.). GP51, which has previously been isolated from rabbit mucosa, appears to function as part of the defense mechanism in an in vivo infection model. GP51 coats the epithelium and is secreted into the urine, as detected by immunohistochemical testing and enzyme-linked immunosorbent assay (ELISA). Increased urinary GP51 occurs during urinary tract infection. To elucidate the role of GP51 as a component of the primary defense mechanism we studied interactions with uropathogenic bacterial isolates and urine from symptomatic patients with urinary tract infection., Materials and Methods: ELISA was performed to demonstrate the binding of GP51 and various uropathogens. Immunochemical studies were done using monoclonal antibodies to GP51 to determine the interaction of GP51 with certain uropathogenic isolates, including Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Proteus vulgaris, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, S. epidermidis and Streptococcus faecalis. Infected urinary sediments and uropathogenic bacterial cultures were examined by immunocytochemical testing to localize GP51. Antigen inhibition ELISA was done to quantitate urinary GP51 in the urine of 17 normal controls and 19 patients with urinary tract infection., Results: ELISA revealed that GP51 binds to a wide spectrum of gram-positive and gram-negative uropathogens in semiquantitative fashion. Immunochemical methods confirmed that purified GP51 binds to bacteria, encapsulating and aggregating the bacteria. Clinical specimens showed GP51 localized to bacteria and uroepithelial cells. We observed a significant increase in urinary GP51 in urinary tract infection compared to uninfected urine (p = 0.0003)., Conclusions: These studies suggest that GP51, a component of bladder mucin, may be a strategic factor in the primary defense mechanism of the bladder.
- Published
- 2001
- Full Text
- View/download PDF
9. Low serum insulin-like growth factor 1 (IGF-1): a significant association with prostate cancer.
- Author
-
Baffa R, Reiss K, El-Gabry EA, Sedor J, Moy ML, Shupp-Byrne D, Strup SE, Hauck WW, Baserga R, and Gomella LG
- Subjects
- Adenocarcinoma blood, Adenocarcinoma surgery, Aged, Enzyme-Linked Immunosorbent Assay, Humans, Male, Middle Aged, Postoperative Period, Preoperative Care, Prostate-Specific Antigen analysis, Prostatectomy methods, Prostatic Neoplasms blood, Prostatic Neoplasms surgery, Reference Values, Sensitivity and Specificity, Adenocarcinoma diagnosis, Biomarkers, Tumor analysis, Insulin-Like Growth Factor I analysis, Prostatic Neoplasms diagnosis
- Abstract
Purpose: Insulin-like growth factor 1 (IGF-1) is an important mitogenic and antiapoptotic peptide that affects the proliferation of normal and malignant cells. Contradictory reports on the association between serum IGF-1 level and prostate cancer have been highlighted in the recent literature. The purpose of this study was to investigate the relation between serum levels of IGF-1 and prostate cancer., Materials and Methods: We analyzed a population of 57 patients who underwent radical prostatectomy (RP) for adenocarcinoma. Serum samples were collected before RP (T0), 6 months after RP (T6), and from 39 age-matched controls. IGF-1 levels were determined by the active IGF-1 Elisa kit (Diagnostic Systems Laboratories, Inc.). Parallel samples were evaluated for prostate-specific antigen (PSA) levels. Data between groups were analyzed using Welch's t-test and levels before RP and after 6 months were compared by paired t-test., Results: The normal mean serum IGF-1 for case patients at T0 (124.6+/-58.2 ng/mL) was significantly lower than the control subjects (157.5+/-70.8 ng/mL; p = .0192). The normal mean serum IGF-1 for case patients at T0 (124.91+/-58.6 ng/mL) also was significantly lower when it was compared with the T6 group (148.49+/-57.2 ng/mL; p = .0056). No association was found between IGF-1 and PSA blood levels, or IGF-1 and patient weight (p = 0.2434). An inverse relation between IGF-1 levels and age in the normal controls (p = .0041) was observed., Conclusion: Findings of this study indicate a significant association between low serum levels of IGF-1 and prostate cancer.
- Published
- 2000
10. Analysis of tumor spillage during radical prostatectomy using RT-PCR of prostate specific antigen.
- Author
-
Moreno JG, Shenot PJ, Shupp-Byrne D, and Gomella LG
- Subjects
- Combined Modality Therapy, DNA Primers chemistry, Epithelium pathology, Follow-Up Studies, Humans, Male, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Polymerase Chain Reaction methods, Prostatic Neoplasms etiology, Prostatic Neoplasms pathology, RNA, Messenger analysis, Spectrophotometry, Treatment Outcome, Neoplasm Recurrence, Local etiology, Prostate-Specific Antigen genetics, Prostatectomy adverse effects, Prostatic Neoplasms surgery, RNA, Neoplasm analysis
- Abstract
Recent reports have suggested the shedding of cancer cells during radical extirpation of tumors. Prostate cells can be expressed from the prostate ex vivo and found in the expressed prostatic secretions. We conducted an in vivo study to determine if prostate epithelial cells can be found in the operative site as determined by RT-PCR targeted at prostate specific antigen (PSA) and to correlate this with pathologic stage and outcome. We analyzed 14 consecutive radical retropubic prostatectomy procedures with a minimum 1-year follow-up. Intraoperatively, 5-10 ml of fluid (representing blood, urine, and irrigant) was aspirated from the operative field at three time points: after transaction of the dorsal vein complex, urethra, and bladder neck. Ficoll gradient fractionation was carried out on the specimens, and RNA was extracted from the cell pellet. Quality of RNA and presence of the PSA mRNA was determined by RT-PCR targeted at actin and PSA, respectively, using previously published primers. The medical records were reviewed for pathologic stage. There were nine patients with extraprostatic disease and five patients with organ confined disease. Five of 14 (36%) patients tested positive for prostate epithelial cells in the operative field at one or more points during radical prostatectomy. All five positive RT-PCR PSA assays were in patients with locally advanced disease, whereas all of the patients with organ-confined disease were negative for RT-PCR. This preliminary in vivo study suggests that locally advanced prostate cancer may be associated with PSA expressing cells in the operative field during radical prostatectomy. The clinical significance of this is unclear, but this finding suggests that shedding of cells in the operative field is more likely with locally advanced disease.
- Published
- 1996
11. The presence of an antibacterial glycoprotein in a spectrum of transitional gel carcinomas.
- Author
-
Moldwin RM, Shupp-Byrne D, Callahan HJ, and Mulholland SG
- Subjects
- Bacterial Adhesion, Female, Glycoproteins physiology, Humans, Male, Carcinoma, Transitional Cell chemistry, Glycoproteins analysis, Urinary Bladder Neoplasms chemistry
- Abstract
The mucin lining of the bladder is thought to serve as a primary defense mechanism against bacterial colonization, and has recently been implicated in the urothelial resistance to carcinogenic insult. We have isolated a unique glycoprotein fraction (GP1) of this lining from the normal rabbit bladder which may have a function in preventing bacterial adherence and colonization in the urinary tract. This glycoprotein has been shown to bind to a wide range of uropathic bacteria. The present study examines changes in the bladder's antibacterial defense mechanisms as measured by GP1 expression in the neoplastic state. Using an anti-GP1 serum, immunohistochemical staining was performed on 20 paraffinized and fresh frozen transitional cell carcinomas ranging from low grade, superficial tumors to high grade, invasive tumors. The presence of GP1 was seen throughout the mucosal layer in normal specimens with increased amounts noted towards the mucosal surface. Progressively decreased expression was noted with increasing grades of all transitional carcinoma specimens. Mucosal field changes in GP1 expression were not noted in any of the patients. Intestinal mucosal controls failed to detect the presence of GP1. These studies suggest that the expression of GP1 decreases with tumor dedifferentiation and that bladder tumorogenesis may serve a role in handicapping the bladder's primary antibacterial defense mechanism.
- Published
- 1992
- Full Text
- View/download PDF
12. The production of antibodies to pentosanpolysulfate (ELMIRON, SP-54).
- Author
-
Callahan HJ, Shupp-Byrne D, Pizzo M, Parsons CL, and Mulholland SG
- Subjects
- Animals, Cystitis drug therapy, Enzyme-Linked Immunosorbent Assay, Heparin pharmacology, Humans, Immunization, Pentosan Sulfuric Polyester isolation & purification, Rabbits, Antibody Formation, Pentosan Sulfuric Polyester immunology
- Abstract
Pentosanpolysulfate (PPS) represents the product obtained after sulfation of xylan and is composed of beta 1----4-D-xylopyranose residues sulfated at C2 and C3. Studies have shown that this compound can often be effective in relieving the symptoms of interstitial cystitis (IC). In order to elucidate the mode of action of PPS in IC, a sensitive and reliable assay was needed. To this end we prepared an immunogenic form of PPS by coupling it to methylated bovine serum albumin (MBSA). This complex was used to immunize NZW rabbits (1 mg, IM). Four of five animals responded with anti-PPS antibodies, three of which had high titer (greater than 1/2000) as measured by an enzyme-linked immunosorbent assay (ELISA). All sera were routinely absorbed with an MBSA-Sepharose immunoadsorbent to remove anti-MBSA antibodies. ELISA inhibition tests were used to determine the sensitivity and specificity of the sera. At least 50 ng/ml of PPS could be routinely detected by this assay. A number of naturally occurring proteoglycans, polysaccharides, monosaccharides and disaccharides were examined for reactivity with the antibodies but only heparin was an effective inhibitor. Absorption with heparin immunoadsorbents reduced, but did not eliminate, the ability of heparin to inhibit anti-PPS binding. This activity could be destroyed by treatment with heparinase without affecting PPS inhibition. Normal urine did not affect the ELISA or ELISA inhibition tests and thus allowed the determination of PPS levels in IC patient urines. Initial analysis of seven IC patients receiving oral PPS revealed urine concentration of 0.8-16.0 micrograms/ml. No inhibition could be detected in pre-treatment urine samples.
- Published
- 1991
- Full Text
- View/download PDF
13. "Embryonic" collagen (type I trimer) alpha 1-chains are genetically distinct from type I collagens alpha 1-chains.
- Author
-
Shupp-Byrne DE and Church RL
- Subjects
- Animals, Cell Line, Collagen immunology, Collagen isolation & purification, Enzyme-Linked Immunosorbent Assay, Macromolecular Substances, Mice, Peptide Fragments, Peptide Hydrolases, Procollagen genetics, Staphylococcus aureus enzymology, Tendons analysis, Teratoma analysis, Collagen genetics
- Abstract
Our laboratory has previously demonstrated that cell lines derived from early embryonic mouse sources produce procollagen and collagen and suggested that this material represents a new genetic type of collagen. Evidence was presented using carboxymethyl cellulose chromatography, analytical isoelectric focusing, cyanogen bromide peptide analysis, amino acid analysis, and carbohydrate analysis which demonstrated that this "embryonic" collagen consisted of three identical alpha-chains, distinctly different from types I, II and III and IV collagen and thus probably represented a new type of collagen. Further evidence is presented using Staphylococcus aureus V-8 protease generated peptide maps and immunological studies using antisera prepared against "embryonic" collagen and procollagen. These data clearly demonstrated that "embryonic" collagen is clearly distinct from type I alpha-chains and represents a unique genetic species of collagen.
- Published
- 1982
- Full Text
- View/download PDF
14. Assignment of the genes for mouse type I procollagen to chromosome 16 using mouse fibroblast-Chinese hamster somatic cell hybrids.
- Author
-
Shupp Byrne DE and Church RL
- Subjects
- Animals, Chromatography, DEAE-Cellulose, Chromosome Mapping, Cricetinae, Cricetulus, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Fibroblasts ultrastructure, Genes, Hybrid Cells, Mice, Procollagen genetics
- Abstract
Somatic cell hybrids between mouse and Chinese hamster fibroblasts have been used to identify the chromosome responsible for the synthesis of both mouse type I procollagen subunit chains (MCOLA1 and MCOLA2). Thirty-one separate hybrid clones and subclones from ten separate hybridization events were isolated in hypoxanthine-aminopterin-thymidine (HAT) selection medium and were used for detailed gene-mapping studies. ELISA and "Western blotting" immunochemical analysis were used to detect the production of mouse type I procollagen in each hybrid clone. Mouse and Chinese hamster chromosomes were identified in each hybrid clone by trypsin-Giemsa banding of metaphase chromosome spreads and by isozyme analysis. We have found that mouse type I procollagen production segregates concordantly with mouse superoxide dismutase-1, previously mapped to mouse chromosome 16, and with the presence of mouse chromosome 16 karyotypically. Western blotting immunochemical analysis of the separated mouse procollagen chains produced by each hybrid line demonstrated that apparently the genes for both subunit chains are located on the same chromosome. These studies, therefore, assign the structural genes for mouse type I procollagen pro alpha 1 (MCOLA1) and pro alpha 2 (MCOLA2) chains to mouse chromosome 16.
- Published
- 1983
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.